NEWS ROOM

See the latest news from our company below or use the search feature. For more information, contact our head office or the Marketing Communications Manager directly at marcom@arazygroup.com.


 

2017 RAPS REGULATORY CONVERGENCE: BOOTH 300/SEPTEMBER 12 LECTURE, 1.15PM

by Arazy Group | Jun 28, 2017
MedTech regulatory affairs professionals managing the launch of products in new markets and maintaining market approval globally will benefit from the invaluable insights shared during the ‘Regulatory Strategies & Techniques for Faster Market Access’ session at this year’s RAPS Regulatory Convergence.

The 90-minute session, taking place at 1.15pm on Tuesday 12th September, will explore the advanced methods and tools that are enabling in vitro diagnostic (IVD) and medical device firms to manage product registration processes in multiple countries simultaneously, quickly and more cost-effectively than ever.

Kicking off the session, Maham Ansari, Director of Regulatory Affairs at MedTech firm Synaptive, will outline the importance of building global requirements into the design of the device from the concept phase, engaging regulatory affairs, senior management and other departments from the very beginning of the product’s development to deal with changing global regulations, communicate those to key stakeholders within their companies and develop regulatory strategies that will make their companies successful globally.

In part two of the session, Benny Arazy, CEO of Arazy Group Consultants Inc, and founder of the LICENSALE.COM registration platform, will demonstrate the current technology solutions that enable regulatory affairs professionals to effectively execute, process and manage multiple product registrations in any number of countries, access global markets a few months sooner than current practices allow and achieve it independently of the local distributor or other third party. Delegates will learn how the use of the most advanced product registration technology available to the MedTech industry aligns the organization’s business and regulatory strategies towards generating growth while accelerating time-to-market, significantly cutting all associated costs and ending up in full ownership of the desired market sales approval. 

Furthermore, Arazy Group will be at Booth 300 ready to answer attendee questions and to give LICENSALE.COM demonstrations. To book a meeting with the team in advance, please visit: www.arazygroup.com/events.  

 

 

Back to Press Room

latest news
  • Sep 19 2017
    REGULATORY UPDATE - SPD

    Korea: SPD's CB11 was approved for sale with LICENSALE.COM®. ...

    Read More
  • Sep 6 2017
    REGULATORY UPDATE - SPD

    Philippines: SPD's IVD products CBDOT were approved for sale with LICENSALE.COM®. ...

    Read More
  • Aug 31 2017
    REGULATORY UPDATE - CORTEX

    USA: Cortex's Dental implants and Prosthetic Devices were approved for sale with LICENSALE.COM®...

    Read More
  • Aug 10 2017
    REGULATORY UPDATE - SPD

    Ethiopia: SPD's CB11, CB9 & CBDOT were approved for sale with LICENSALE.COM®. ...

    Read More
  • Aug 8 2017
    REGULATORY UPDATE - XERIDIEM

    Saudi Arabia: Xeridiems' Entuit family was approved for sale with LICENSALE.COM®. ...

    Read More

VANCOUVER OFFICE

  • Phone +1 604.681.6888
  • Fax +1 604.681.6822
  • info@arazygroup.com
  •  
  • #350-1333 Johnston Street
  • Pier 32, Granville Island
  • Vancouver, British Columbia
  • Canada V6H 3R9

BACK TO TOP